Travere Therapeutics, Inc. (TVTX) Financials

TVTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 788.9 million 588.1 million
2023-09-30 832.9 million 553.1 million
2023-06-30 736.4 million 619.9 million
2023-03-31 808.2 million 619.1 million

TVTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -76.0 million 8.1 million
2023-09-30 -64.7 million 10.7 million
2023-06-30 -72.5 million 11.6 million
2023-03-31 -109.1 million 13.8 million

TVTX Net Income

No data available :(

TVTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 566.9 million - 27.5 million
2023-09-30 634.6 million - 28.6 million
2023-06-30 491.3 million 376.4 million 29.8 million
2023-03-31 561.5 million 376.0 million 30.9 million

TVTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 76.5 million
2023-09-30 76.3 million
2023-06-30 76.0 million
2023-03-31 68.2 million

TVTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 5.5 million 58.7 million 63.6 million -10.9 million
2023-09-30 5.6 million 60.6 million 67.8 million -
2023-06-30 3.2 million 69.4 million 75.9 million -
2023-03-31 28.0 million 59.9 million 79.0 million -

TVTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 45.1 million 16.4 million
2023-09-30 37.1 million 1.3 million
2023-06-30 59.7 million 2.0 million
2023-03-31 57.0 million 5.1 million

TVTX

Price: $6.26

52 week price:
5.12
19.54

Earnings Per Share: -5.07 USD

P/E Ratio: -1.88

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.1 million

Market Capitalization: 476.4 million

Links: